Cargando…

Assessment of Glucose Lowering Medications’ Effectiveness for Cardiovascular Clinical Risk Management of Real-World Patients with Type 2 Diabetes: Targeted Maximum Likelihood Estimation under Model Misspecification and Missing Outcomes

The results from many cardiovascular (CV) outcome trials suggest that glucose lowering medications (GLMs) are effective for the CV clinical risk management of type 2 diabetes (T2D) patients. The aim of this study is to compare the effectiveness of two GLMs (SGLT2i and GLP-1RA) for the CV clinical ri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sciannameo, Veronica, Fadini, Gian Paolo, Bottigliengo, Daniele, Avogaro, Angelo, Baldi, Ileana, Gregori, Dario, Berchialla, Paola
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9690556/ https://www.ncbi.nlm.nih.gov/pubmed/36429543 http://dx.doi.org/10.3390/ijerph192214825

Ejemplares similares

Similar effectiveness of dapagliflozin and GLP‐1 receptor agonists concerning combined endpoints in routine clinical practice: A multicentre retrospective study
por: Fadini, Gian Paolo, et al.
Publicado: (2019)

Prediction of treatment outcome in clinical trials under a personalized medicine perspective
por: Berchialla, Paola, et al.
Publicado: (2022)

Use and effectiveness of dapagliflozin in routine clinical practice: An Italian multicentre retrospective study
por: Fadini, Gian Paolo, et al.
Publicado: (2018)

Comparative Effectiveness of DPP-4 Inhibitors Versus Sulfonylurea for the Treatment of Type 2 Diabetes in Routine Clinical Practice: A Retrospective Multicenter Real-World Study
por: Fadini, Gian Paolo, et al.
Publicado: (2018)

Adjustment for Baseline Covariates to Increase Efficiency in RCTs with Binary Endpoint: A Comparison of Bayesian and Frequentist Approaches
por: Berchialla, Paola, et al.
Publicado: (2021)

Transposition of cardiovascular outcome trial effects to the real-world population of patients with type 2 diabetes
por: Sciannameo, V., et al.
Publicado: (2021)

Propensity Score Analysis with Partially Observed Baseline Covariates: A Practical Comparison of Methods for Handling Missing Data
por: Bottigliengo, Daniele, et al.
Publicado: (2021)

Evaluating treatment effectiveness under model misspecification: A comparison of targeted maximum likelihood estimation with bias-corrected matching
por: Kreif, Noémi, et al.
Publicado: (2014)

The Role of Genetic Factors in Characterizing Extra-Intestinal Manifestations in Crohn’s Disease Patients: Are Bayesian Machine Learning Methods Improving Outcome Predictions?
por: Bottigliengo, Daniele, et al.
Publicado: (2019)

Oversampling and replacement strategies in propensity score matching: a critical review focused on small sample size in clinical settings
por: Bottigliengo, Daniele, et al.
Publicado: (2021)

Phenomapping of Patients with Primary Breast Cancer Using Machine Learning-Based Unsupervised Cluster Analysis
por: Ferro, Sara, et al.
Publicado: (2021)

Time-resolved trajectory of glucose lowering medications and cardiovascular outcomes in type 2 diabetes: a recurrent neural network analysis
por: Longato, Enrico, et al.
Publicado: (2022)

Early termination of cardiovascular trials as a consequence of poor accrual: analysis of ClinicalTrials.gov 2006–2015
por: Baldi, Ileana, et al.
Publicado: (2017)

Accrual monitoring in cardiovascular trials
por: Baldi, Ileana, et al.
Publicado: (2017)

Prior Elicitation for Use in Clinical Trial Design and Analysis: A Literature Review
por: Azzolina, Danila, et al.
Publicado: (2021)

The Surplus Transplant Lung Allocation System in Italy: An Evaluation of the Allocation Process via Stochastic Modeling
por: Lanera, Corrado, et al.
Publicado: (2021)

A topic trend analysis on COVID-19 literature
por: Urru, Sara, et al.
Publicado: (2022)

Cholesterol lowering therapies and achievement of targets for primary and secondary cardiovascular prevention in type 2 diabetes: unmet needs in a large population of outpatients at specialist clinics
por: Morieri, Mario Luca, et al.
Publicado: (2020)

Challenges and opportunities in real‐world evidence on the renal effects of sodium‐glucose cotransporter‐2 inhibitors
por: Fadini, Gian Paolo, et al.
Publicado: (2021)

It Is All in the Blood: The Multifaceted Contribution of Circulating Progenitor Cells in Diabetic Complications
por: Fadini, Gian Paolo, et al.
Publicado: (2012)

How to interpret the role of SDF-1α on diabetic complications during therapy with DPP-4 inhibitors
por: Fadini, Gian Paolo, et al.
Publicado: (2018)

Two-stage maximum likelihood approach for item-level missing data in regression
por: Chen, Lihan, et al.
Publicado: (2020)

Scale-up Approach in CATI Surveys for Estimating the Number of Foreign Body Injuries in the Aero-digestive Tract in Children
por: Snidero, Silvia, et al.
Publicado: (2012)

Screening PubMed abstracts: is class imbalance always a challenge to machine learning?
por: Lanera, Corrado, et al.
Publicado: (2019)

COVID-19 hospitalizations and patients' age at admission: The neglected importance of data variability for containment policies
por: Azzolina, Danila, et al.
Publicado: (2022)

Amelioration of Glucose Control Mobilizes Circulating Pericyte Progenitor Cells in Type 2 Diabetic Patients with Microangiopathy
por: Fadini, Gian Paolo, et al.
Publicado: (2012)

On the consequences of model misspecification in logistic regression.
por: Begg, M D, et al.
Publicado: (1990)

Effectiveness of adding alarms to flash glucose monitoring in adults with type 1 diabetes under routine care
por: Boscari, Federico, et al.
Publicado: (2022)

A Bayesian Sample Size Estimation Procedure Based on a B-Splines Semiparametric Elicitation Method
por: Azzolina, Danila, et al.
Publicado: (2022)

Three Sample Estimates of Fraction of Missing Information From Full Information Maximum Likelihood
por: Chen, Lihan, et al.
Publicado: (2021)

Glucagon-like peptide-1 receptor agonists are not associated with retinal adverse events in the FDA Adverse Event Reporting System
por: Fadini, Gian Paolo, et al.
Publicado: (2018)

Pharmacovigilance Evaluation of the Association Between DPP-4 Inhibitors and Heart Failure: Stimulated Reporting and Moderation by Drug Interactions
por: Fadini, Gian Paolo, et al.
Publicado: (2018)

Managing diabetes in diabetic patients with COVID: where do we start from?
por: Avogaro, Angelo, et al.
Publicado: (2021)

Maximum Penalized Likelihood Estimation
por: LaRiccia, Vincent N, et al.
Publicado: (2009)

Maximum-likelihood density modification
por: Terwilliger, Thomas C.
Publicado: (2000)

Misspecification of Cox regression models with composite endpoints
por: Wu, Longyang, et al.
Publicado: (2012)

Genetic model misspecification in genetic association studies
por: Gaye, Amadou, et al.
Publicado: (2017)

Infection Rates and Impact of Glucose Lowering Medications on the Clinical Course of COVID-19 in People with Type 2 Diabetes: A Retrospective Observational Study
por: Mannucci, Francesca, et al.
Publicado: (2022)

Maximum Likelihood and Restricted Likelihood Solutions in Multiple-Method Studies
por: Rukhin, Andrew L.
Publicado: (2011)

Long-Acting Injectable GLP-1 Receptor Agonists for the Treatment of Adults with Type 2 Diabetes: Perspectives from Clinical Practice
por: Morieri, Mario Luca, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_i8fqgopegbmq2lfot5l7fe48q3